A Process-Based Assessment (PBA) is the first step to analyzing reporting needs
The current economic downturn may fuel the creation of new, more sustainable business models
Strategic and proactive thinking are vital in providing supply chain leaders with an opportunity to shift their focus to a more holistic, value-centered approach.
Dana Edwards shares strategies and best practices for developing and implementing high-tech, high-touch patient support programs for innovative and novel therapies to help connect patients to the services they need.
How pharma can harness digitalization all the way through commercialization
In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.
Six engagement tips for companies to consider to improve patient use of portals
Focusing on key groups will drive the greatest impact in health outcomes
Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
Although companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.
The rationale behind transforming case management in healthcare.
Digital transformation initiatives are often complex endeavors that can significantly impact the way organizations operate.
Outlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Faster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.
Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.
The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
How current frameworks influence coverage decisions and pricing negotiations.
Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible
Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.
Amid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.
How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape
FDA approves COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax targeting the LP.8.1 sublineage of SARS-CoV-2, with eligibility limited to adults aged 65 years and older and those with underlying medical conditions that place them with a high risk for severe disease.
How artificial intelligence is improving the patient experience
While this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue
A comprehensive data and analytics strategy is now table stakes for pharmaceutical and life science organizations, writes Simon Andrews